Welcome to the Nautilus first quarter 2025 earnings conference call. At this time, all participants are in listen-only mode. After the speaker's pressentation, there will be a question and answer ...

Nautilus Biotechnology, Inc. ( NASDAQ: NAUT) Q1 2025 Earnings Conference Call April 29, 2025 8:30 AM ET Ji-Yon Yi - Head, Investor Relations Sujal Patel - Co-Founder & Chief Executive Officer Parag ...

Q1 2025 Earnings Call Transcript April 29, 2025 Nautilus Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0 ...

Welcome ladies and gentlemen to AstraZeneca's Q1 2025 Results Conference Call for Investors and Analysts ... that we've actually achieved our target sample size in the CAMBRIA-1 study just ...

Operator: Good day, and thank you for joining us. Welcome to the ECARX First Quarter 2025 Earnings Conference Call. At this ...

Anti-doping experts have told elite athletes to avoid one-night stands to limit their chances of being contaminated with ...

For eight years running, Finland has been rated the happiest country in the world by a peculiar United Nations-backed project ...

Together, it amounted to a class of techno-industrialists gathering in Washington not to question President Donald Trump’s ...

According to 56 min clip released by SAD's Bikram Majithia, Khadoor Sahib MP Amritpal had strong connections with slain ...

In this episode of the Why and Gold Talk Podcast, host Ethan Sands, along with Chris Fedor and Jimmy Watkins, discuss the ...

Oncocyte has completed its clinical trial design and has received approval from a large central institutional review board (IRB), which is a committee that reviews and oversees the safety and ethics ...

Central Institutional Review Board approved, final preparatory steps underway at first transplant centersThree of the top 10 U.S. transplant centers expected to participate in trialNearly 10% of annua ...